Denne gennemgang, der sluttede i oktober 2005, gav ikke anledning til nye sikkerhedsmæssige betænkeligheder for klassen af NSAID som helhed.
This review, which concluded in October 2005, did not reveal any new safety concerns for the class of NSAIDs as a whole.